chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Loss of taste  could taste a little, muted taste; Arm tenderness; This spontaneous case was reported by a health care professional and describes the occurrence of TENDERNESS (Arm tenderness) and AGEUSIA (Loss of taste  could taste a little, muted taste) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 025J20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Jan-2021, the patient experienced TENDERNESS (Arm tenderness). On 29-Jan-2021, the patient experienced AGEUSIA (Loss of taste  could taste a little, muted taste). At the time of the report, TENDERNESS (Arm tenderness) and AGEUSIA (Loss of taste  could taste a little, muted taste) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jan-2021, SARS-CoV-1 test negative: negative (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment details were not provided.
pt recvd 2nd dose of vax inadvertently; devel fever & myalgia; sxs resolved w/in 2 hrs;
Injection site reaction, itching, swelling, and redness. ALLEGRA 180 mg daily, PEPCID AC 20 mg twice daily, BENADRYL 25 mg 2 tabs at bedtime for itching. Hydrocortisone cream 1% twice daily.
Left axillary LAD and suspect a large local reaction to the superior left deltoid s/p COVID-19 Moderna booster given on 7 jan 2022 with focal TTP, calor, eythema although no edema, no rash, no urticaria of the left deltoid. Mild pain with movement flex/ext mostly focal TTP to the injection site. Not suspicious of a skin infection at this time.
The patient got Moderna as her first dose and was given Pfizer as the second dose. The patient did not have an adverse reaction to our knowledge at this time.
Severe heartburn and severe right abdominal pain. It took 6 weeks for abdominal pain to completely subside. I took ranitidine, tums and ate a very bland diet.
Severe pain, arm redness approx 15cm swelling-leaving indurated SQ mass;
PATIENT WAS GIVEN SHOT AFTER THE BEYOND USE DATE. PFIZER WAS CALLED. THERE WAS NO REPORT  FROM PATIENT OF SIDE EFFECTS.
Admitted with chest pain on 6/7/2021. EKG showed Pericarditis. Troponin peaked at 33. Patient discharge on NSAIDs with follow up in cardiology clinic in 2 weeks.
09/26/2007 - VACCINE GIVEN IN LEFT DELTOID 09/27/2007 - FATIGUE AND NOTICED LUMP AND TENDERNESS IN LEFT AXILLARY.
Myalgia, Arthralgia, Fever, NauseaVomiting & Palpitations Narrative: Employee had the first dose of moderna vaccine on 7/12/21, 1100am. she stated that she developed progressing weakness, muscle ache, joint pain. she stated that she left her job at noon on 7/13/21, she missed work on 7/14/21. On 7/15/2021, she claimed that she felt better able to come to work. the body ache/ joint pain had resolved. she stated that she took 800mg of Motrin
After 2nd dose of COVID-19 Vaccine received 4/23/2021 the following symptoms appeared:  12 hours post-dose:   Fever (101.2F) Chills Headache Body aches (muscle, joint and low-back pain) Lethargy  48 hrs post-dose: Pain, swelling, and itching in Left armpit (same side as injection)
Had a migraine next day after first shot.  Haven't had a migraine in over 10 years.  Lasted one day.  Fine the next day.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose12/23/21 2nd dose01/13/21 Diagnosed covid positive:09/13/21 Symptom onset:09/12/21 Exposure:community Symptoms:fever, fatigue,muscle aches,loss of smell/taste,chills, runny nose,HA
Arthralgia Narrative: Body aches day after injection, felt better later in the day.
Pt recv vax on 10/20/98; on 10/24/98 pt exp fever, chills, bones aching, head tight, vomit for 3 day.
Extreme fatigue, swollen lymph node near collarbone, nausea on day two post second vaccination
Back part of left arm was swollen approximately 3 inches in diameter, red, and hot to touch.  Gave benadryl 2 1/2 teaspoons q 6 hours, applied cool compress for 10 mins off for 30 mins through out the night.
he "doesn't feel well"; feeling flushed; This is a spontaneous report from a Pfizer sponsored programs and regulatory authority Support. A contactable consumer (patient) reported that a 74-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 27Feb2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient received first dose of BNT162B2 for COVID-19 immunisation on an unspecified date. The patient's medical history was not reported. Concomitant medication included paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported. It was reported that the patient "doesn't feel well" and is "feeling flushed". He explained he took a Tylenol and asked if it is ok to take such medication post vaccination. The outcome of the events was unknown.    Follow-up attempts are completed. No further information is expected.
ALTERED TASTE/FOOD NOT TASTING SAME; ALTERED SMELL/CONSTANT SMELL OF SCENT; This spontaneous report received from a patient via a company representative concerned a 50 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the patient experienced altered taste/food not tasting same. On APR-2021, the patient experienced altered smell/constant smell of scent. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from altered taste/food not tasting same, and altered smell/constant smell of scent.  This report was non-serious.
Pt recvd 2nd dose of vax in rt deltoid area on 9DEC91 exp erythema, swelling, & pain in rt deltoid muscle down to elbow; by the next wk had recovered;
Some pts received vx after being exposed to 29 F; This case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in an unspecified number of patients who received HBV (Engerix B) for prophylaxis.   On an unknown date, the patient received Engerix B. On an unknown date, unknown after receiving Engerix B, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Lot number and expiry date was not provided. The reporter stated that, some patients received Engerix B after being exposed to 29 degree Fahrenhiet, which led to incorrect storage of drug. The reporter provided limited information since he did not have access to patient'ss demographic information. The reporter did not consent to follow-up.
Large, red, raised, swollen, hot, itchy lump on arm for 4 days.
Patient has history of lightheadedness with vaccination.   Patient became lightheaded immediately post vaccination.    Patient was placed in observation area.  B/P 100/49, Pulse 90, O2 100%.    At 1101 patient had increased lightheadedness B/P 89/40/ Pulse 87, O2 100%.    EMS was called .   1105 - B/P 131/75 Pulse 110. o2 100%.   1109 EMS arrived patient refused EMS and patient left with father at 1112.
I have been experience rapid heartbeat, and irregular heartbeat since November 3rd, 2021.   Varying degrees of intensity, causing trouble sleeping and great anxiety.   My blood pressure is about 20pts higher than normal.  My pulse is about 10-15 beats per minute higher than normal.   My heart has been steady for my entire life, and I am quite frightened that the symptoms are permanent.  The NP that I saw regarding this had not heard of such adverse reactions but it is listed on the CDC website as an adverse reaction to the J & J Janssen vaccine.   My next step will be asking the NP for a referral to a cardiologist or internal medicine doctor.
My mother was the patient in question She had a Moderna Covid Vaccine in Feb/March of 2021.  She then had 2 doses of Rituxan on April 28th of 2021.  After her second dose of the medication, she tested positive for covid 3 days later. She was hospitalized on May 8th and was not able to recover. She passed away on May 20th.  The Drs at the Hospital in told me the rituxan essentially wiped the vaccine from her body.  The reason I'm reporting this is to warn others in her position about the possible side effects. My mom had a very false sense of security.
I had a sore throat, runny nose, a cough. I was also tired and periodically I had chills.
I had my second COVID shot at 36 weeks, 6 days pregnant. My due date is April 16. I had no problems immediately after the shot except soreness in my arm. However, that night, I started to feel groggy. When I woke up the next morning my body was achy and I felt very fatigued. A few hours later I started vomiting and had diarrhea. My stomach was cramping. I felt like I had a fever but couldn't find a thermometer to check on that. It felt like I had some kind of stomach virus. I did have some kind of stomach bug about three weeks ago that made me so dehydrated I had an IV in the hospital. For that illness I was prescribed diphenoxylate-atropine 2.5-0.025 mg to take at home. I still had some of that medicine left, so I took one of those pills hoping to stop my diarrhea. I didn't want dehydration or cramping to affect my pregnancy. The medicine did stop my diarrhea and vomiting, but I still had all the other symptoms until the middle of the night. I woke up feeling better.
I tested positive for COVID-19 on 06/21/2022. I had a sore throat at first. Then, I had a headache, body aches, coughing that was very painful, and dizziness. I was prescribed Paxlovid and I started feeling better after taking that after about four days.
soreness/pain at injection site (had a very hard time utilizing that arm); headache (probably a migraine); nausea; general body aches; chills; low grade temp 100; tired; general feeling unwell; This is a spontaneous report from a contactable health care professional nurse, the patient. A 34-years-old non-pregnant female patient (nurse) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EK9231), intramuscular in the left arm on 31Dec2020 16:15 as a single dose,  for COVID-19 vaccination.  Medical history included asthma from an unknown date and unknown if ongoing and Know Allergy to Latex. Concomitant medication included budesonide (PULMICORT), albuterol [salbutamol] (ALBUTEROL [SALBUTAMOL]), magnesium (MAGNESIUM), cyanocobalamin (VIT B12). No other vaccines were given within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 01Jan2021 04:30, the patient experienced soreness/pain at injection site (had a very hard time utilizing that arm), headache (probably a migraine), nausea, general body aches, chills, low grade temp 100, tired, general feeling unwell. No treatment was given for the event. Laboratory test include Body Temperature 100 on an unspecified date. The clinical outcome of Soreness/pain at injection site (had a very hard time utilizing that arm), headache (probably a migraine), nausea, general body aches, chills, low grade temp 100, tired, general feeling unwell recovered Jan2021.    .
Recurring Raised Rash- redness , swelling, sometimes hard, sometimes an "eye" in the center, soreness, itchiness, warm to the touch Location- Left arm- upper near injection site and below, lower, wrist, middle finger    Possible right side of neck- similar symptoms- April 2021- exact date unknown Duration- approximately 3-7days per each occurrence Dates- 4/24- upper arm at injection site, 5/24 upper arm at injection site, 6/7 outer lower arm,  6/13, wrist and upper arm, 6/14 middle finger, 6/15- outer arm near elbow  Prescribed - Cephalexin Capsules,  Methylprednisolone Dospak, Fluocinonide Cream
patient received under dose of medication; needle broke off; Arexvy leaked out onto the patient skin; Arexvy leaked out onto the patient skin; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of accidental underdose in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On 19-SEP-2023, the patient received Arexvy (intramuscular). On 19-SEP-2023, an unknown time after receiving Arexvy, the patient experienced accidental underdose (Verbatim: patient received under dose of medication), needle broken (Verbatim: needle broke off), exposure via skin contact (Verbatim: Arexvy leaked out onto the patient skin) and inadvertent exposure to vaccine (Verbatim: Arexvy leaked out onto the patient skin).  The outcome of the accidental underdose, needle broken, exposure via skin contact and inadvertent exposure to vaccine were unknown.   Additional Information: GSK Receipt Date: 19-Sep-2023 The pharmacist stated that the needle broke off while administering the Arexvy causing the patient to receive an under dose of the medication and also, the medication Arexvy leaked out onto the patient skin when the needle broke off which led to accidental underdose, needle broken, exposure via skin contact and inadvertent exposure to vaccine. The reporter questioned whether or not the remaining part of the dose should be given later or just give the initial dose once more. The reporter was transferred to Medical Information for these questions and was given medical disclaimer and was referred to Healthcare professional. The reporter consented to follow up.
The pt returned to the office 20 minutes post vax with a localized purpuric rash on lower legs, the left leg is worse.
This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient. A 35-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 30Dec2020 as dose 1, single (Batch/Lot number: unknown), in left arm, on 20Jan2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 20Aug2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 34 years, in left arm for Covid-19 immunisation; CoviD-19 vaccine miRNA (miRNA 1273) (MODERNA COVID-19 VACCINE), on 03Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for Covid-19 immunisation. The patient's relevant medical history included: "Primary Mediastinal B Cell Lymphoma", start date: 12Mar2020 (unspecified if ongoing), notes: Primary Mediastinal B Cell Lymphoma diagnosed treatment completed 30 Mar2021; "remission" (unspecified if ongoing), notes: have remained in remission. Concomitant medication(s) included: Celexa [Celecoxib]; Wellbutrin; Pepcid [Famotidine]; Vitamin C [Ascorbic Acid]; Afrin [Oxymetazoline]; Fluticasone Propionate; Tylenol; Ibuprofen. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "COVID-19 Treatment". Therapeutic measures were taken as a result of Covid-19. The patient had no known allergies. The information on the batch/lot number for [BNT162B2] was not provided and will be requested during follow up. Sender's Comments: As there is limited information in the case provided, the causal association between the reported events and the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
1 by 2 dozen blisters on my large toes; This case was reported by a consumer and described the occurrence of blister in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, immediately after receiving Shingrix, the patient experienced blister. On an unknown date, the outcome of the blister was unknown.   It was unknown if the reporter considered the blister to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. Since getting the 1st of Shingrix the patient experienced about 1 by 2 dozen blisters on patient's large toes for no explainable reason. The patient asked Is that a possible side effect. For tolerance after 2nd dose of Shingrix, refer case US2020AMR106672.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR106498:1st dose
Severe chills first night, arm red and swollen from shoulder to elbow 2 days later
Upset stomach; Frequent Bowel Movements; This case was reported by a consumer via call center representative and described the occurrence of upset stomach in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th September 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 15th September 2019, less than a day after receiving Shingrix, the patient experienced upset stomach and frequent bowel movements. On an unknown date, the outcome of the upset stomach and frequent bowel movements were not recovered/not resolved.   It was unknown if the reporter considered the upset stomach and frequent bowel movements to be related to Shingrix.  Additional information received were as follows: On sunday, in the early afternoon, the patient received Shingrix on right arm. Within 12 hours of receiving the vaccination, the patient began to experience an upset stomach and frequent bowel movements. The patient reported that she had 4 to 5 bowel movements in the last 24 hours and that was more than she normally experienced, The patient stated that it was not diarrhea just increased frequency of bowel movements and indicated that the symptoms were starting to lessen as the day progresses.  The reporter consented to follow up. The reporter gave permission for her physician to be contacted. The reporter was unable to provide additional information.
Pt's mother reports the 3-4 hours after the injection pt's leg was red and swollen, pt would not put weight on the leg. Pt had a fever that reached 102.5, she reported the event to us and was told to monitor the pt's sx, she called again on 6/21 and said sx have improved but were not completely resolved, she was told that if pt worsens to bring her into the clinic to be checked.
Fever (high fever 102+), head Cold, Upset Stomach, sinus, migraine, muscle pain,  joint ache
Small hives on forearms 10 min post vaccine.  Pt observed.  50 min. post vaccine slight increase in hives.  25mg Benadryl given PO.  VS stable , Pt released.
pt recvd vax; red, swollen, warm to touch at inject site; 25jan94 tx w/ DPH; resolved 18oct93;
Initial report was received 27 July 2009 from another manufacturer (reference number WAES 0906USA04755), who received the report from a health care professional. The following is verbatim from the report: "Information has been received from a nurse practitioner concerning a 5 year old male patient who on 11-MAY-2009 was vaccinated with a second dose of MMRII (lot # 663519/1771X) 0.5ml, subcutaneously. Concomitant therapy also given on 11-MAY-2009, included tuberculin purified protein derivative (manufacturer unknown), DAPTACEL and IPOL. After he got the three shots and before he got MMRII "his head leaned over to the side like he had passed out". The nurse grabbed him and he started having "seizure like movements". Oxygen was administered as an intervention to prevent serious criteria. The office called 911, and he was transported to the emergency room but was not admitted. He was still having "seizure like movements" when he was taken from the office. There was no information whether or not the seizure like movements stopped and then restarted before he was taken from the office or if they lasted from when they first started until he was taken from the office. Unspecified date the patient recovered. Electroencephalography (EEG) and blood work were performed, results not reported" "Follow up information has been received via telephone call from the nurse who indicated the physician had set the patient up with a neurologist to rule out seizure disorder. The patient had no problems after receiving the first dose of MMRII." "Follow up information has received from a health care professional concerning a 5 year old male patient with no pertinent medical history and no known drug allergies, who on 11-MAY-2009 was vaccinated with the second dose of MMRII (lot # 663519/1771X) in the right deltoid, a fifth dose of DAPTACEL (lot# C3139AA) in the left deltoid and a fourth dose of POLIOVAX (Lot # B0009) in the left deltoid at 2:30 pm. On 11-MAY-2009 after given the last dose of MMRII the patient started shaking, his eyes rolled back, then he started seizuring. The patient required a visit to emergency room/doctor visit. On 11-MAY-2009, the patient recovered." "Upon internal review seizure was determined to be an other important medical event. No further information is available." Upon receipt of the above information from the other manufacturer, it was determined that (Lot # B009) (previously referred to in the above paragraph as POLIOVAX), pertained to IPOL. Documents held by sender: None.
Swollen and itchy tongue; Swollen and itchy tongue; This is a spontaneous report from a contactable Nurse (patient). A 50-Year-old non-pregnant female patient received first dose ofBNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN9581, Expiry date: unknown) via unspecified route of administration on 31Jan2021 at 10:45 AM (at the age of 50-years-old) at a single dose for covid-19 immunisation. Medical history included Known allergies, never had allergic reaction before. Concomitant medication patient received within 2 weeks of vaccination included 50 mcg  Levothyroxine, 10mg lisinopril, 67mg Fenofibrate. The patient experienced Swollen and itchy tongue on 31Jan2021 at 11:30 AM. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment was received for the adverse event. The outcome of all the events was recovered in 2021.